Cellenion logo — Experts in single cell isolation technology for sequencing a...

Cellenion

Experts in single cell isolation technology for sequencing and cell line development applications.

Founded 2016 France France 25 employees Biotechnology, Health Care +2

General Information

Company Name Cellenion
Founded Year 2016
Location France France +1
Employees 25
Industries Biotechnology, Health Care, Life Sciences +1
Social

Get notified when Cellenion moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Cellenion

Cellenion is a biotechnology startup that specializes in single cell isolation technology for sequencing and cell line development applications. The company has developed and patented CellenONE, a breakthrough technology that enables precise single-cell isolation and dispensing. This technology addresses a long-standing challenge in the scientific community, offering high throughput and unmatched recovery in manipulating micrometric-sized and delicate cells. Additionally, Cellenion is involved in bioprinting, utilizing 3D printing technologies to create spatially-controlled cell patterns. The company aims to achieve miniaturization and automation to produce reproducible models of varying complexities. Since its establishment in 2016, Cellenion operates within the Biotechnology, Health Care, Life Sciences, and Clean Energy industries, demonstrating its potential for widespread impact and innovation. Despite the absence of specific information about the headquarter and last investment, Cellenion's pioneering technology and applications position it as an intriguing prospect for potential venture capital investment.

Taxonomy: Single cell isolation, Single cell dispensing, Bioprinting, Cell line development, Sequencing technology, Cell manipulation, Patented technology, High-throughput, Precision technology, Cellular analysis, Biomedical research, Laboratory technology, Microfluidics

No funding data available for Cellenion yet.

Get notified when Cellenion raises funding

Cellenion Alternatives & Competitors

Cellenion vs
Namocell
Namocell United States

The Fastest Way to Single Cells

Series A
8 employees
Biotechnology, Life Sciences
Cellenion vs

Solutions, Instrumentation and Assays for Cell & Molecular Biology

33 employees
Cellenion vs

We’re the droplet microfluidic technology company for single cell analysis. We work small so you can...

Series Unknown
99 employees
Biotechnology, Life Sciences

FAQ About Cellenion

Experts in single cell isolation technology for sequencing and cell line development applications.
Cellenion was founded in 2016.
Cellenion is headquartered in France.
Cellenion operates in the following industries: Biotechnology, Health Care, Life Sciences, Clean Energy.
Cellenion has approximately 25 employees.
Top alternatives and competitors to Cellenion include Namocell, Biotron Healthcare (India) Pvt. Ltd, Sphere Fluidics Limited, Cell Microsystems, Samplix. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cellenion and Namocell are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Cellenion and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy